Slow-releasing injection contg. platinum compounds and cytotoxin type anticarcinogen
A technique for sustained-release injections and compounds, applied in the field of preparation of sustained-release injections, sustained-release implants, and anti-cancer sustained-release injections, which can solve problems such as many complications, poor curative effect, and difficult operation
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Examples
Embodiment 1
[0115] Put 80mg of polyphenylpropane (p-CPP: 20:80 of sebacic acid (SA)) copolymer into a container, add 100ml of dichloromethane, dissolve and mix well, then add 10mg Hydroxycamptothecin and 10 mg succinoplatin were re-shaken and spray-dried to prepare microspheres for injection containing 10% hydroxycamptothecin and 10% succinoplatin. Then suspend the microspheres in physiological saline containing 15% mannitol to prepare the corresponding suspension-type sustained-release injection with a viscosity of 220cp-460cp (at 20°C-30°C). The drug release time of the slow-release injection in physiological saline in vitro is 10-15 days, and the drug release time in mice subcutaneous is about 20-30 days.
Embodiment 2
[0117] The method step of processing into sustained-release injection is the same as that of Example 1, but the difference is that the contained anticancer active ingredients and their weight percentages are: 2-40% of sulfoplatin, dicycloplatin, eplatin, meciplatin, cyproplatin, etc. Alizarin or picoplatin with 2-40% hydroxycamptothecin, mitozolomide, 4-carboxytemozolomide, docetaxel, ifosfamide, lomustine, estramustine, formustine , samustine, etoposide, teniposide, vinblastine, anastrozole, tamoxifen, fluorouracil or mitomycin C; the sustained-release excipients used are racemic polylactic acid, Racemic Polylactic / Glycolic Acid Copolymer, Monomethylpolyethylene Glycol / Polylactic Acid, Monomethylpolyethylene Glycol / Polylactic Acid Copolymer, Polyethylene Glycol / Polylactic Acid, Polyethylene Glycol / Polylactic Acid Copolymer, carboxy-terminated polylactic acid or carboxyl-terminated polylactic acid / glycolic acid copolymer.
Embodiment 3
[0119] Put 70 mg of polylactic acid (PLGA, 75:25) with a peak molecular weight of 65,000 into a container, add 100 ml of dichloromethane, dissolve and mix well, add 15 mg of eplatin and 15 mg of lomustine, re-shake and dry in vacuum Remove organic solvents. The dried drug-containing solid composition was frozen and pulverized to make micropowder containing 15% eplatin and 15% lomustine, and then suspended in physiological saline containing 1.5% carboxymethylcellulose sodium to prepare the corresponding mixed Suspension-type sustained-release injection with a viscosity of 300cp-400cp (at 20°C-30°C). The drug release time of the slow-release injection in physiological saline in vitro is 18-25 days, and the drug release time in mice subcutaneous is about 40-50 days.
PUM
Property | Measurement | Unit |
---|---|---|
Viscosity | aaaaa | aaaaa |
Viscosity | aaaaa | aaaaa |
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com